In a welcome initiative, digital COVID-19 vaccination certificates will now be issued to the participants of clinical trials of Serum Institute of India manufactured Covishield and Bharat Biotech’s COVAXIN through Co-WIN portal, Union Health Minister Mansukh Mandaviya said on Monday.
The certificates will be a token of thanks for their contribution to the vaccine research and treatment in the country. “The nation thanks them for their incredible commitment and contribution to COVID-19 vaccine research and treatment,” he said.
In a welcome initiative, digital #COVID19 vaccination certificates will now be issued to the clinical trial participants of COVISHIELD & COVAXIN through Co-WIN.The nation thanks them for their incredible commitment & contribution to COVID-19 vaccine research & treatment. (1/2)
— Mansukh Mandaviya (@mansukhmandviya) August 23, 2021
The participants can download their individual certificates through Co-WIN Portal, Aarogya Setu, Digilocker or the UMANG Application, he said.
So far, Bharat Biotech’s Covaxin has completed its phase III large clinical trials that found it to be 78% effective in preventing symptomatic infection. The study of children is going on.
Serum Institute of India’s Covishield has completed its immunogenicity bridging trial to show that it produces a similar immune response as seen elsewhere.
Read all the Latest News, Breaking News and Assembly Elections Live Updates here.
Comments
0 comment